Gene analysis (cystatin b) of full sequence
Medicare pricing data for 39 providers across 8 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (cystatin b) of full sequence (HCPCS code 81189) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $268.69, but hospitals typically charge $334.13 — a 1.2x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $268.69, your out-of-pocket cost would be approximately $53.74. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $268.69 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Louisiana | $269 | $304 | 2 | 78 | +0.2% |
| Maryland | $269 | $413 | 1 | 11 | +0.2% |
| New Jersey | $269 | $506 | 4 | 3,039 | +0.2% |
| Oklahoma | $269 | $359 | 3 | 337 | +0.2% |
| Pennsylvania | $269 | $278 | 1 | 1,107 | +0.2% |
| Arizona | $269 | $300 | 1 | 79 | +0.2% |
| Florida | $269 | $370 | 12 | 934 | +0.0% |
| Texas | $268 | $281 | 14 | 9,351 | -0.1% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber